NCT00423397 2013-12-19
Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
Clinical Trials
3 trialsNCT00253474 2012-03-29
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00047879 2011-10-26
Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas
National Institutes of Health Clinical Center (CC)
Phase 2 Completed